22NW, LP
Follow13F filer, CIK 1694297, SEATTLE, WA
22NW, LP reported $158,530,698 across 16 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14. Its ten largest share positions make up 93.11% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-25-002859
- Period
- 2024-12-31
- Reported value
- $159M
- Holdings
- 16
- Top 10 weight
- 93.11%
- New
- 4
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ANEBadded | +10,101,010 | $17M |
| SRInew | +342,787 | $2.15M |
| NEKTAR THERAPEUTICSnew | +2,191,750 | $2.04M |
| UFInew | +233,777 | $1.46M |
| PMDInew | +276,034 | $618K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| PSYCHEMEDICS CORPexited | -276,034 | -$638K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0001214659-25-002859, largest first. % of portfolio is the value over $158,530,698, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| FSTRFOSTER L B CO | 1,313,121 | $35.3M | 22.28% | 0 | Timeline | ||
| LFCRLIFECORE BIOMEDICAL INC | 1,755,161 | $31.1M | 19.65% | 0 | Timeline | ||
| ANEBANEBULO PHARMACEUTICALS INC CO | 15,467,300 | $26M | 16.39% | +10,101,010 | Timeline | ||
| STRLSTERLING INFRASTRUCTURE INC | 99,783 | $16.8M | 10.6% | 0 | Timeline | ||
| BBSIBARRETT BUSINESS SVCS INC | 264,904 | $11.5M | 7.26% | 0 | Timeline | ||
| CULPCULP INC | 1,624,715 | $9.54M | 6.02% | +30,325 | Timeline | ||
| PFXPHENIXFIN CORP | 117,885 | $5.92M | 3.74% | 0 | Timeline | ||
| DHXDHI GROUP INC | 2,603,643 | $4.61M | 2.91% | 0 | Timeline | ||
| FARMFARMER BROS CO | 1,955,526 | $3.52M | 2.22% | 0 | Timeline | ||
| MTWMANITOWOC CO INC | 356,115 | $3.25M | 2.05% | 0 | Timeline | ||
| LNTHLANTHEUS HLDGS INC | 34,562 | $3.09M | 1.95% | 0 | Timeline | ||
| SRISTONERIDGE INC | 342,787 | $2.15M | 1.36% | new | Timeline | ||
| NEKTAR THERAPEUTICSNEKTAR THERAPEUTICS | 2,191,750 | $2.04M | 1.29% | new | |||
| SSKNSTRATA SKIN SCIENCES INC COM S | 536,995 | $1.56M | 0.98% | 0 | Timeline | ||
| UFIUNIFI INC | 233,777 | $1.46M | 0.92% | new | Timeline | ||
| PMDIPSYCHEMEDICS CORP COM PAR $.00 | 276,034 | $618K | 0.39% | new | Timeline |
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| PSYCHEMEDICS CORPPSYCHEMEDICS CORP | 276,034 | $638K | shares |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001214659-25-002859 | base | 2025-02-14 | acceptance time not in the bulk data set |